Overview
Raf Van De Plas practices in Delft, Netherlands. Van De Plas is rated as an Experienced expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. Their top areas of expertise are Optic Glioma, Late-Onset Retinal Degeneration, Squamous Cell Lung Carcinoma, and Neurofibromatosis Type 1 (NF1).
Their clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Late-Onset Retinal DegenerationVan De Plas isExperienced. Learn about Late-Onset Retinal Degeneration.
- Neurofibromatosis Type 1 (NF1)Van De Plas isExperienced. Learn about Neurofibromatosis Type 1 (NF1).
- Niemann-Pick DiseaseVan De Plas isExperienced. Learn about Niemann-Pick Disease.
- Optic GliomaVan De Plas isExperienced. Learn about Optic Glioma.
- Squamous Cell Lung CarcinomaVan De Plas isExperienced. Learn about Squamous Cell Lung Carcinoma.